The FDA fined Nova Vascular (NOVARX), a compounding pharmacy, for making false claims about cheap copies of semaglutide and tirzepatide on its website. The company claimed its drugs were FDA-approved and sourced from FDA-approved pharmacies, which is illegal — compounded drugs are not FDA-approved, and pharmacies don't get FDA licenses.

• •FDA issued warning letter to Nova Vascular LLC dba NOVARX on June 8, 2026
• •NOVARX website claimed compounded drugs sourced from 'FDA Approved Pharmacies' — false per FDA
• •FDA reviewed NOVARX website at https://novarx.co in March 2026; FEI 3044022416